The Role of CK7, S100A1, and CD82 (KAI1) Expression in the Differential Diagnosis of Chromophobe Renal Cell Carcinoma and Renal Oncocytoma.


Creative Commons License

Sari Z. B., Açikalin M. F., Arik D., Özen A., Can C., Çolak E.

Applied immunohistochemistry & molecular morphology : AIMM, cilt.29, sa.7, ss.534-540, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 7
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1097/pai.0000000000000916
  • Dergi Adı: Applied immunohistochemistry & molecular morphology : AIMM
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Biotechnology Research Abstracts, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.534-540
  • Anahtar Kelimeler: chromophobe renal cell carcinoma, oncocytoma, CK7, CD82, CYTOKERATIN 7, IMMUNOHISTOCHEMICAL BIOMARKERS, NEOPLASMS, UTILITY, MARKER, TUMORS, CAVEOLIN-1, VIMENTIN, BIOPSY, CD117
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Renal oncocytoma is a benign renal tumor originated from intercalated cells of collecting ducts like chromophobe renal cell carcinoma (RCC). The differential diagnosis of these 2 tumors is important because while they are histologically and cytologically similar, they show different biological behavior. For the differential diagnosis, several immunohistochemical markers have been investigated. But, differential diagnostic challenges remain and the identification of additional markers is needed. Cytokeratin 7 (CK7) is one of ductal-type keratins, which is expressed in tumors of breast, pancreas, lung, thyroid, ovary, endometrium, urinary bladder, and the kidney. S100A1 is the first defined member of the calcium-binding S100 protein family and it organizes several cellular functions including cell cycle progression and cell differentiation.CD82 is a tetraspanin membrane protein, which functions as a metastasis supressor. In this study, we immunohistochemically investigated the expressions of CK7, S100A1, and CD82 in 30 chromophobe RCC (23 classic and 7 eosinophilic variant) and 19 oncocytomas. When these markers were evaluated separately and together, their expressions in chromophobe RCC and renal oncocytoma show statistically significant difference (P<0.001). Similar statistically significant results were also seen between eosinophilic chromophobe RCC and oncocytoma (P<0.001). For both classic and eosinophilic-variant chromophobe RCCs, CK7(+)/S100A1(-)/CD82(+) profile being the most common. In oncocytomas, the most frequently observed profile was CK7(-)/S100A1(+)/CD82(-). Our results showed that the application of a panel consisting of CK7, S100A1, and CD82 may provide accurate categorization of the tumors in difficult cases.